Once our researchers have determined your eligibility, you will participate in our study for up to 8 weeks.
After a pretreatment screening and lead-in period of 2 weeks, you will receive antidepressant medication for 4 weeks.
After the end of treatment, you will be evaluated for 2 weeks.